Less may be more: lung cancer surgery showdown

NCT ID NCT07169903

Not yet recruiting Disease control Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times

Summary

This study compares two types of lung cancer surgery for people with a specific kind of lung cancer (adenocarcinoma) that is 2-3 cm in size. One surgery removes a small part of the lung (segmentectomy), while the other removes a larger section (lobectomy). The goal is to see if the smaller surgery works just as well at preventing the cancer from coming back, while possibly helping people keep more of their lung function. About 587 adults aged 20-79 will take part, and they will be followed for 5 years after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, 200433, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LUNG ADENOCARCINOMA